Great! Both Xiamen SpaceSeq and Suzhou SpaceSeq passed the National Inter-laboratory Quality Assessment of Solid Tumor Somatic Mutation high-throughpu

Recently, the NCCL released the results of the "2024 National Inter-laboratory Quality Evaluation Report on Solid Tumor Somatic Mutation Detection in high-throughput sequencing". The results of the reports of Xiamen SpaceSeq MedLab Co., Ltd. (abbreviated as "Xiamen SpaceSeq") and Suzhou SpaceSeq MedLab Co., Ltd. (abbreviated as "Suzhou SpaceSeq"), wholly-owned subsidiaries of Xiamen Spacegen, showed that there were no points deducted, no false positives or false negatives. Once again, both Xiamen SpaceSeq and Suzhou SpaceSeq MedLab successfully passed the quality evaluation of the project with full scores of excellent results. It fully demonstrates that the testing ability and sound quality management system of Xiamen SpaceSeq and Suzhou SpaceSeq have been affirmed by the national authoritative institutions again.

#01

The inter-laboratory quality evaluation covered all somatic mutations included in the sequencing panel, including multiple mutation types such as single nucleotide variation (SNV), insertion and deletion (Indel), copy number variation (CNV) and structural variation (SV). The results of samples submitted by Xiamen SpaceSeq and Suzhou SpaceSeq were completely consistent with the expected results, fully demonstrating the professionalism, accuracy and stability of the detection and bioinformatics analysis and interpretation capabilities of Xiamen SpaceSeq and Suzhou SpaceSeq in high-throughput sequencing.

With the rapid development of high-throughput sequencing technology, high-throughput sequencing has been gradually applied in clinical practice by laboratory research. high-throughput sequencing with tumor gene mutation has important guiding significance for the diagnosis, targeted therapy and prognosis judgment of clinical tumor patients.

#02

For a long time, Xiamen SpaceSeq and Suzhou SpaceSeq have always adhered to high standards and strict requirements to provide high-quality clinical testing services. In the future, Xiamen SpaceSeq and Suzhou SpaceSeq will, as always, meticulously build standardized and standardized quality control system to continuously improve the level of laboratory technical services. At the same time continue to actively participate in domestic and international quality assessment of various types of assessment, make persistent efforts, and constantly open up for doctors and patients to provide high-quality products and professional services!